Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-13-003093
Accepted
2013-10-29 00:15:11
Documents
1
Effectiveness Date
2013-10-28
Registration Form
F-10

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 589
  Complete submission text file 9999999995-13-003093.txt   1697
Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3
Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: EFFECT | Act: 33 | File No.: 333-191907 | Film No.: 131174572
SIC: 2834 Pharmaceutical Preparations